World Investment Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$610K Buy
15,897
+887
+6% +$38.1K 0.01% 871
2026
Q1
$552K Buy
15,010
+1,607
+12% +$76.1K 0.01% 936
2025
Q4
$682K Sell
13,403
-4,706
-26% -$241K 0.01% 815
2025
Q3
$1M Buy
18,109
+635
+4% +$37.2K 0.02% 563
2025
Q2
$1.21M Sell
17,474
-1,624
-9% -$110K 0.03% 475
2025
Q1
$1.33M Sell
19,098
-2,608
-12% -$215K 0.03% 435
2024
Q4
$1.87M Buy
21,706
+7,781
+56% +$841K 0.05% 339
2024
Q3
$1.66M Buy
13,925
+3,750
+37% +$500K 0.05% 325
2024
Q2
$1.45M Buy
10,175
+8,579
+538% +$1.14M 0.09% 207
2024
Q1
$205K Sell
1,596
-534
-25% -$63.6K 0.03% 376
2023
Q4
$220K Buy
+2,130
New +$211K 0.03% 351

Other funds holding NVO

World Investment Advisors's NVO Position: Q2 2026 in Review

World Investment Advisors increased its Novo Nordisk (NVO) stake by 5.9% in Q2 2026, buying an estimated $38.1K and bringing the position to 15,897 shares worth $610K. The position accounts for 0.01% of the portfolio, ranked #871.

World Investment Advisors first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.87M in Q4 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • World Investment Advisors held 15,897 shares of Novo Nordisk worth $610K as of Q2 2026.
  • World Investment Advisors bought 887 Novo Nordisk shares in Q2 2026, an estimated $38.1K.
  • Novo Nordisk made up 0.01% of World Investment Advisors's portfolio in Q2 2026, its #871 holding.
  • World Investment Advisors first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • World Investment Advisors's Novo Nordisk position peaked at $1.87M in Q4 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.